BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14614615)

  • 1. Biclonal multiple myeloma in liver cirrhosis due to hepatitis C virus infection.
    Tashiro M; Tabaru A; Narita R; Sugihara Y; Otsuki M
    J Gastroenterol; 2003; 38(10):1017-8. PubMed ID: 14614615
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma.
    Montella M; Crispo A; Russo F; Ronga D; Tridente V; Tamburini M
    Haematologica; 2000 Aug; 85(8):883-4. PubMed ID: 10942947
    [No Abstract]   [Full Text] [Related]  

  • 4. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis of decompensated hepatitis C virus related cirrhosis].
    Wu CH; Tian GS; Wang QH; Yu YY; Dou YQ; Xu XY
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):516-9. PubMed ID: 18649764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
    Merchante N; Jiménez-Saenz M; Pineda JA
    AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma.
    Rodríguez-García A; Linares M; Morales ML; Allain-Maillet S; Mennesson N; Sanchez R; Alonso R; Leivas A; Pérez-Rivilla A; Bigot-Corbel E; Hermouet S; Martínez-López J
    Front Immunol; 2021; 12():797209. PubMed ID: 35087522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The development of multiple myeloma in chronic diffuse liver diseases with a long course of monoclonal immunoglobulinopathy (a description of 2 cases)].
    Krel' PE; Andreeva NE; Aprosina ZG
    Ter Arkh; 1991; 63(8):130-4. PubMed ID: 1792603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
    Choi J; Lim YS
    EBioMedicine; 2017 Feb; 15():6-7. PubMed ID: 27979732
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis.
    Hara T; Nishi S; Horimoto A; Takenaka S; Ibata Y; Akamatsu H
    J Gastroenterol Hepatol; 2001 Aug; 16(8):948-9. PubMed ID: 11555118
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
    Pradat P; Tillmann HL; Sauleda S; Braconier JH; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban JI; Hadziyannis S; Rizzetto M; Thomas H; Manns MP; Trepo C;
    J Viral Hepat; 2007 Aug; 14(8):556-63. PubMed ID: 17650289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural history of hepatitis C].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):102. PubMed ID: 14980113
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of the C virus in the chronicity of viral hepatitis].
    Claici C; Nicoară E; Roşiu N; Strain R; Vâlculescu C; Chidiosan CM; Nicolescu I; Cioflec D; Claici D; Don E
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):70-2. PubMed ID: 7981531
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.
    Silvestri F; Barillari G; Fanin R; Zaja F; Infanti L; Patriarca F; Baccarani M; Pipan C; Falasca E; Botta GA
    Blood; 1996 Aug; 88(3):1125-6. PubMed ID: 8704227
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis.
    Viganò M; Aghemo A; Iavarone M
    Gastroenterology; 2007 Dec; 133(6):2076. PubMed ID: 18054591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.